https://www.avient.com/sites/default/files/2024-12/67599-Certificate-06DEC2024.pdf
Administration, Site Management, Manufacture, Laboratory, Procurement, Supply Chain Management, Engineering and Maintenance, Infrastructure, Warehouse and Transport C/Carretera.
https://www.avient.com/sites/default/files/2024-05/3b - Corporate Governance Guidelines.Draft Feb. 2024.v1.2.Revised.4-16-24.Final_.pdf
Has personally received, or has an immediate family member who has received, during any twelve-month period within the last three years, more than $120,000 in direct compensation from the Company, other than compensation for Board or Committee service (provided such compensation is not contingent in any way upon continued service) or compensation paid to an immediate family member for service as a non-executive employee of the Company; C. These committees operate in accordance with (a) their respective charters, which are reviewed annually, (b) applicable law, and (c) applicable rules of the Securities and Exchange Commission and the New York Stock Exchange.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Gabelli%2520%2526%2520Co%2520Specialty%2520Chemicals%2520Conference.pdf
The New PolyOne: A Specialty Growth Company Segment Highlights 16POLYONE CORPORATION 1.7% 4.6% 5.1% 5.5% 7.2% 8.1% 9.7% 12.2% 14.7% 16.7% 16.0% 2017 Revenue: $0.9 Billion United 46% 31% Asia 15% Latin South (27%) (14%) (10%) Textiles (12%) (8%) 15.5% Color, Additives & Inks 17POLYONE CORPORATION 1.1% 1.3% 3.4% 5.1% 9.6% 8.0% 8.6% 9.3% 12.1% 14.7% United 48% 28% 22% (20%) (19%) Electrical & Electronics (15%) (13%) (11%) 12.5% 2017 Revenue: $0.6 Billion Operating Income % of Sales 14.3% Specialty Engineered Materials 18POLYONE CORPORATION 5.5% 6.9% 3.8% 3.6% 5.5% 4.3% 6.3% 7.2% 7.7% 8.3% 12-14% 10.7% 11.1% United 77% 16% Latin 5% Building & Construction (30%) (16%) (15%) (18%) 2017 Revenue: $0.7 Billion Operating Income % of Sales Performance Products & Solutions 19POLYONE CORPORATION 23% 22% 18% 15% Appliance 7% E & E 6% B & C 3% W & C 38% ROIC* 2.6% 3.0% 3.5% 4.6% 5.6% 6.4% 5.9% 6.1% 6.6% 6.5 - 7.5%6.3% *After-Tax ROIC 6.4% 2017 Revenue: $1.2 Billion Key Suppliers 4.0% Distribution http://www.avient.com/Pages/VariationRoot.aspx http://www.avient.com/Pages/VariationRoot.aspx Target End Markets & Application Examples 21POLYONE CORPORATION Thermally Conductive Chemical Resistant Polymer Colorants Elastomeric Grips and Handles Structural Composites Antimicrobial Technologies Anti-Counterfeiting Target End Markets… Healthcare Catheter Technologies 22POLYONE CORPORATION Under-hood Components Target End Markets… Automotive Interior Structural Components Sound & Vibration Management Roof Systems Air Management Electronics and Cameras Lighting Exterior / Interior Trim Braces & Brackets Fasteners Seals & Flaps 23POLYONE CORPORATION Target End Markets… Consumer Thermally Conductive Components Polymer Colorants Elastomeric Grips and Handles Structural Composite Components 24POLYONE CORPORATION Oxygen Scavenger Laser Marking Additives Antistatic Technologies UV Light Barrier Technologies Cap & Closure Colorants Process Optimization Antioxidant Technologies Density Modified Technologies Target End Markets… Packaging 25POLYONE CORPORATION Impart weight, sound and metallic finish to caps and closures for cosmetics and spirits applications Elevate quality and prestige perceptions among high-end consumers Eliminate time and cost associated with secondary operations and assembly Luxury Packaging GravitechTM Density Modified Polymers 26POLYONE CORPORATION Optimize Color Usage OnColorTM Super Concentrates Eliminate costs by increasing pigment density Enhance color performance without altering form and formulation Increasing design capabilities by reducing weight and layer thickness 27POLYONE CORPORATION Combat Bacteria Formation WithStandTM Antimicrobial Technology Inhibit microbial growth on polymer surfaces Enhance value or products and devices Highly versatile concentrate with the ability to be incorporated into a wide variety of products 28POLYONE CORPORATION Medical Device Housings Chemically Resistant Engineered Polymers Durable, long-lasting products stand up to the most aggressive disinfectants Minimize environmental stress cracking and discoloration One of the broadest medically approved polymer and colorant portfolios 29POLYONE CORPORATION Color & Design Services Greater control of color development and supply chain Work across entire design process from concept to commercialization Inspire creativity in the use of polymer materials, colors, and effects Innovative brand differentiation Faster development timelines 30POLYONE CORPORATION Outdoor Applications Leading provider of high performance specialty materials for the recreational and sports & leisure industry Well positioned across all segments to address market needs Metal to Polymer Conversion Lightweighting Thermal Management Impact Performance 31POLYONE CORPORATION ColorMatrix Fiber Colorant Proprietary advanced liquid color formulations and equipment enable greater efficiency and productivity Eliminates aqueous dyeing and its associated wastewater treatment Solid Color Concentrates Extrusion-spun fibers colored via solid masterbatch Fiber Colorants 32POLYONE CORPORATION Smart Home Devices ResilienceTM Vinyl Solutions High flame retardancy to meet strict UL standards Greater processing and design flexibility Specialized additives provide long term color stability Diffusive lens materials improve light dispersion 1 Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to PolyOne common shareholders, adjusted earnings per share (EPS) attributable to PolyOne common shareholders and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance.
https://www.avient.com/sites/default/files/2023-07/AVNT Q2 2023 Earnings Presentation%5B70%5D.pdf
AVIENT CORPORATION S E C O N D Q U A R T E R 2 0 2 3 R E S U L T S (NYSE: AVNT) J U LY 2 7 , 2 0 2 3 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Additionally, Adjusted EPS excludes the impact of special items and amortization expense associated with intangible assets. 2 COMPOSITES PORTFOLIO D Y N E E M A ® E X P A N D S O U R E N G I N E E R E D F I B E R S A N D P A N E L S T E C H N O L O G Y LFT Tapes Laminates/Panels Shapes Pultrusion Engineered Fibers 4 DEFENSE TELECOMMUNICATIONS ENERGY TRANSPORTATION Military • Law Enforcement First Responders Body Armor • Helmets Vehicle Protection Sustainable Infrastructure Offshore Wind Electrical Grid Protection EV Battery Components Commercial Laminates Body & Trim • Air Cargo and Railroad Car Panels 5G Applications Fiber Optic Cables Satellite Communications Connectors and Components 5 COMPOSITES SERVE DIVERSIFIED END MARKETS INDUSTRIAL Lifting Slings • Aquaculture High Pressure Pipe Conveyer Springs Q 2 P ER FO RM A N CE Q2 2023 PERFORMANCE VS.
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for Czech Republic.pdf
C 87503, IQAP Czech, s.r.o., with the seat at Prumyslová 451, Planá nad Luznici, 391 02, Czech Republic, registered in the commercial register maintained by the Regional court in České Budějovice under file no. C 13832, and Avient S.à r.l., acting through its branch Avient S.à r.l.
https://www.avient.com/sites/default/files/2025-05/AVNT May Investor Presentation_w_non-GAAP_0.pdf
EPS $2.66 Copyright © . 2025 4 Key messages Avient is evolving to its next phase as an innovator of materials solutions to help our customers succeed, while enabling a sustainable world Our primary focus is on organic revenue growth and margin expansion ► intersect secular trends and high growth markets with our technologies ► build businesses in high growthcatalyze growth in our core markets ► hybridization Our strategy is enabled and driven by our focus on (a) portfolio prioritization, (b) amplifying innovation, (c) digital for operational excellence and growth, and (d) leadership, talent and culture for the Avient of the future 5Copyright © . Avient 2024 sales BUSINESS SEGMENTS END MARKETS REGIONS 63% S E M C AI 23% 4% 3% Packaging Telecom Energy Defense 41% 35% 18% US & Canada Latin America Europe, Middle East 25Copyright © .
https://www.avient.com/sites/default/files/2021-01/eccoh-cpr-product-bulletin.pdf
LV cable sheathing2 5995 8.0 11.5 155 40 Cca Class C if ECCOH used in combination with high LOI bedding.
https://www.avient.com/sites/default/files/2020-08/eccoh-cpr-product-bulletin.pdf
LV cable sheathing2 5995 8.0 11.5 155 40 Cca Class C if ECCOH used in combination with high LOI bedding.
https://www.avient.com/sites/default/files/2022-06/MEVOPUR Bio-based Solutions Application Bulletin_CN %281%29.pdf
埃万特的产品不为以下目的或用途而设计,也不会宣传或预期用于以下目的或用途:(a) 被美国食品药品监督管理局(FDA)或国际标准化组织(ISO)归类为“植入”类器械的医疗器械;或美国药典(USP)或ISO标准定义的“永久”使用器械;或 (b) 经修订的欧盟指令90/385/EEC中定义的有源植入式医疗器械;或者 (c) 经修订的欧盟指令93/42/EEC中定义的“长期”使用的医疗器械。
https://www.avient.com/sites/default/files/2022-08/MEVOPUR Special Effect Colors Application Bulletin_CN.pdf
埃万特的产品不为以下目的或用途而设计,也不会宣传或预期用于以下目的或用途:(a) 被美国食品药品监督管理局(FDA)或国际标准化组织(ISO)归类为“植入”类器械的医疗器械;或美国药典(USP)或ISO标准定义的“永久”使用器械;或 (b) 经修订的欧盟指令90/385/EEC中定义的有源植入式医疗器械;或者 (c) 经修订的欧盟指令93/42/EEC中定义的“长期”使用的医疗器械。